Cytori Therapeutics (CYTX:NASDAQ) Investor Relations Material

Overview

Cytori is a prominent medical technology company that specializes in using adult regenerative cells from adipose tissue to help patients and physicians around the globe. The company’s devices and instruments, called the Celution System family, are sold in Asian and European markets for reconstructive and cosmetic surgeries. Unfortunately, this system is not available in the US presently. The StemSource line of products is also available globally for cell banking and research purposes.

Frequently Asked Questions

What is Cytori Therapeutics's ticker?

Cytori Therapeutics's ticker is CYTX

What exchange is Cytori Therapeutics traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Cytori Therapeutics's headquarters?

They are based in San Diego, California

How many employees does Cytori Therapeutics have?

There are 51-200 employees working at Cytori Therapeutics

What is Cytori Therapeutics's website?

It is http://www.cytoritx.com

What type of sector is Cytori Therapeutics?

Cytori Therapeutics is in the Healthcare sector

What type of industry is Cytori Therapeutics?

Cytori Therapeutics is in the Biotechnology industry

Who are Cytori Therapeutics's peers and competitors?

The following five companies are Cytori Therapeutics's industry peers:

- Intercept Pharmaceuticals

- Trevi Therapeutics Inc

- Choice Properties REIT

- Paratek Pharmaceuticals

- SIGA